logo
logo

Beacon Therapeutics Appoints Lance Baldo As CEO and Thomas Biancardi As CFO

Beacon Therapeutics Appoints Lance Baldo As CEO and Thomas Biancardi As CFO

07/24/24, 11:04 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgalachua
Industry
therapeutics
biotechnology
health care
Position
chief executive officer
chief financial officer
Beacon Therapeutics Holdings Limited announced the appointment of Lance Baldo, MD as Chief Executive Officer, effective August 12, 2024, and Thomas Biancardi as Chief Financial Officer, effective August 1, 2024, following a $170 million Series B fundraise. The outgoing CEO, Dave Fellows, will assume the role of non-Executive Chairman of the Board in January 2025.

Company Info

Company
Beacon Therapeutics
Location
alachua, florida, united states
Additional Info
Beacon Therapeutics is a new gene therapy company specializing in the ophthalmology space. Its focus is on developing treatments for retinal diseases.

Related People

Th
Thomas hidden
Copy AI Email to Clipboard
Send via Webmail
Go to AI Email Settings
hidden
Lh
Lance hidden
Copy AI Email to Clipboard
Send via Webmail
Go to AI Email Settings
hidden
Dh
David hidden
Copy AI Email to Clipboard
Send via Webmail
Go to AI Email Settings
hidden
hidden
Ah
Abraham hidden
Copy AI Email to Clipboard
Send via Webmail
Go to AI Email Settings
hidden